BioSpace News Archive

As part of its commitment to world-class, innovative cancer care for the Tampa Bay region and beyond, Tampa General Hospital Cancer Institute has established an adult Bone Marrow Transplant and Cell Therapies unit that focuses on treating patients with aggressive blood cancers such as leukemias, lymphomas, multiple myeloma as well as other cancers.

Rocket Pharmaceuticals, Inc. announced the pricing of an underwritten public offering of 6,800,000 shares of its common stock at a public offering price of $14.75 per share.